author-photo

Ryon Graf

Foundation Medicine

11

Papers

20

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

ERBB2 copy number (CN) as a quantitative biomarker for real-world (RW) outcomes to anti-HER2 therapy in advanced gastroesophageal adenocarcinoma (adv GEA).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer.

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (1)
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (2)
Using real-world outcomes to evaluate the predictive power of tissue-assessed genomic biomarkers for taxane versus novel hormonal therapy (NHT) outcomes in metastatic castration-resistant prostate cancer (mCRPC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Real-world overall survival (OS) and time to therapy discontinuation (TTD) of patients (pts) with mCRPC treated with second-generation novel hormonal therapies (NHT) associated with tissue-based comprehensive genomic profiling (CGP).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (15)
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (0)